Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. 1998

C Benz, and S Angermüller, and U Töx, and P Klöters-Plachky, and H D Riedel, and P Sauer, and W Stremmel, and A Stiehl
Department of Medicine, University of Heidelberg, Germany.

OBJECTIVE In cholestatic liver disease, bile acids may initiate or aggravate hepatocellular damage. Cellular necrosis and cell death may be due to detergent effects of bile acids, but apoptosis may also play a role. In cholestasis, the conditions determining either apoptotic or cytolytic cell death are still unclear. Primary rat hepatocytes in culture represent a suitable model to study bile-acid-induced liver damage. METHODS Glycochenodeoxycholic acid, a hydrophobic bile acid, was used to induce cell damage. Tauroursodeoxycholic acid, a hydrophilic bile acid, served as substrate to study possible protective effects of such compounds. To study the time and concentration dependency of bile-acid-induced cytolysis and apoptosis, morphologic alterations, hepatocellular enzyme release and nucleosomal DNA fragmentation were evaluated. RESULTS Bile-acid-induced cytolysis, as indicated by hepatocellular enzyme release and by morphologic signs of membrane destruction, increased with concentration and time. Addition of tauroursodeoxycholic acid to the incubation medium reduced cytolysis significantly, indicating a direct hepatoprotective effect of this bile acid against the detergent action of hydrophobic bile acids. In contrast to cytolysis, apoptosis with DNA fragmentation was induced by low concentrations of glycochenodeoxycholic acid a few hours after incubation. Coincubation with tauroursodeoxycholic acid in equimolar concentrations significantly reduced apoptosis, indicating another direct hepatoprotective effect of tauroursodeoxycholic acid. CONCLUSIONS It seems likely that in severe cholestasis, bile-acid-induced injury of hepatocytes is due mainly to cytolysis, whereas in moderately severe cholestasis apoptosis represents the predominant mechanism of bile acid toxicity. Tauroursodeoxycholic acid may reduce both bile-acid-induced apoptosis and cytolysis.

UI MeSH Term Description Entries
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005999 Glycochenodeoxycholic Acid A bile salt formed in the liver from chenodeoxycholate and glycine, usually as the sodium salt. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is a cholagogue and choleretic. Chenodeoxycholylglycine,Glycine Chenodeoxycholate,Glycochenodeoxycholate,Acid, Glycochenodeoxycholic,Chenodeoxycholate, Glycine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001219 Aspartate Aminotransferases Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1. Aspartate Aminotransferase,Aspartate Transaminase,Glutamic-Oxaloacetic Transaminase,SGOT,Aspartate Apoaminotransferase,Glutamate-Aspartate Transaminase,L-Aspartate-2-Oxoglutarate Aminotransferase,Serum Glutamic-Oxaloacetic Transaminase,Aminotransferase, Aspartate,Aminotransferase, L-Aspartate-2-Oxoglutarate,Aminotransferases, Aspartate,Apoaminotransferase, Aspartate,Glutamate Aspartate Transaminase,Glutamic Oxaloacetic Transaminase,Glutamic-Oxaloacetic Transaminase, Serum,L Aspartate 2 Oxoglutarate Aminotransferase,Serum Glutamic Oxaloacetic Transaminase,Transaminase, Aspartate,Transaminase, Glutamate-Aspartate,Transaminase, Glutamic-Oxaloacetic,Transaminase, Serum Glutamic-Oxaloacetic
D001647 Bile Acids and Salts Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones. Bile Acid,Bile Salt,Bile Salts,Bile Acids,Acid, Bile,Acids, Bile,Salt, Bile,Salts, Bile
D013655 Taurochenodeoxycholic Acid A bile salt formed in the liver by conjugation of chenodeoxycholate with taurine, usually as the sodium salt. It acts as detergent to solubilize fats in the small intestine and is itself absorbed. It is used as a cholagogue and choleretic. Chenodeoxycholyltaurine,Taurine Chenodeoxycholate,Taurochenodeoxycholate,Acid, Taurochenodeoxycholic,Chenodeoxycholate, Taurine

Related Publications

C Benz, and S Angermüller, and U Töx, and P Klöters-Plachky, and H D Riedel, and P Sauer, and W Stremmel, and A Stiehl
June 2004, Hepatology (Baltimore, Md.),
C Benz, and S Angermüller, and U Töx, and P Klöters-Plachky, and H D Riedel, and P Sauer, and W Stremmel, and A Stiehl
December 2003, Gut,
C Benz, and S Angermüller, and U Töx, and P Klöters-Plachky, and H D Riedel, and P Sauer, and W Stremmel, and A Stiehl
January 2013, PloS one,
C Benz, and S Angermüller, and U Töx, and P Klöters-Plachky, and H D Riedel, and P Sauer, and W Stremmel, and A Stiehl
February 2008, Biochemical and biophysical research communications,
C Benz, and S Angermüller, and U Töx, and P Klöters-Plachky, and H D Riedel, and P Sauer, and W Stremmel, and A Stiehl
October 2005, Toxicology,
C Benz, and S Angermüller, and U Töx, and P Klöters-Plachky, and H D Riedel, and P Sauer, and W Stremmel, and A Stiehl
February 1993, Gastroenterology,
C Benz, and S Angermüller, and U Töx, and P Klöters-Plachky, and H D Riedel, and P Sauer, and W Stremmel, and A Stiehl
May 1998, Hepatology (Baltimore, Md.),
C Benz, and S Angermüller, and U Töx, and P Klöters-Plachky, and H D Riedel, and P Sauer, and W Stremmel, and A Stiehl
March 1977, Zentralblatt fur Veterinarmedizin. Reihe A,
C Benz, and S Angermüller, and U Töx, and P Klöters-Plachky, and H D Riedel, and P Sauer, and W Stremmel, and A Stiehl
January 2009, The Journal of biological chemistry,
C Benz, and S Angermüller, and U Töx, and P Klöters-Plachky, and H D Riedel, and P Sauer, and W Stremmel, and A Stiehl
May 1996, Gastroenterology,
Copied contents to your clipboard!